Pharmacist Issued Warning Over Improper Mezolar Claims for Discontinued Medication
Date of Decision: September 8, 2023
Registrant's Role: Pharmacist
Allegations:
- Submitted or permitted claims for Mezolar dispensing that did not occur.
- Lacked effective systems to identify and properly code non-dispensed prescription items.
- Knew Mezolar was not dispensed but still submitted claims, representing a systemic failure.
- Failed to stop repeat prescriptions for discontinued controlled drug and lacked documentation of communication with GP.
- Did not supervise controlled drug prescribing properly and failed to keep records after medication interventions.
Outcome: Warning issued
GPhC Standards Breached:
- Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
- Standard 2.1.6 – Ensure that you do not, whether by your actions or omissions, create a risk to patient care or public safety.
- Standard 2.1.11 – Avoid treating yourself or anyone with whom you have a close personal relationship except for minor ailments or in an emergency.
- Standard 2.1.12 – Ensure you are aware of and adhere to all relevant legislation, and all current standards and guidance which apply to your practice.
- Standard 2.3.1 – Complete records promptly or as soon as reasonably practicable after the patient intervention or activity has occurred.
- Standard 2.3.3 – Ensure all entries in any record are accurate, clearly and legibly written and attributable.
- Standard 3.1.7 – Take all steps that are reasonably necessary to ensure that recorded information is correct and complete. Do not omit relevant information.
Case Summary
Allegations
The case revolved around the registrant, a superintendent pharmacist, who submitted false claims for Mezolar—a Schedule 2 controlled drug—between April 2017 and December 2018. The medication had been discontinued for the patient, his mother, in April 2017 following a switch to Butec patches. Despite this, prescriptions containing Mezolar continued to be received and submitted for payment as if they were dispensed, even though no such supply had been made. These errors extended over a period of approximately one year and involved about 15 occasions of incorrect submissions, totaling £411.54.
The Pharmacy Inspector’s investigation revealed a significant discrepancy: only two of the 17 prescriptions had matching entries in the controlled drug register. The remainder—despite being coded for supply—had no corresponding records or wholesaler purchase history, indicating they were never actually dispensed.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved
1 thought on “Pharmacist Issued Warning Over Improper Mezolar Claims for Discontinued Medication”
Leave a Reply
You must be logged in to post a comment.

can u add AI videos to all cases thank you